Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: A critical analysis of the literature

European Urology

Volumn 61, Issue 2, 2012, Pages 326-340

  Giannarini, Gianluca ^a   Petralia, Giuseppe ^a   Thoeny, Harriet C ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Anatomy, cross sectional; Bladder cancer; Diffusion magnetic resonance imaging; Early detection of cancer; Kidney neoplasms; Lymph nodes; Neoplasm staging; Prostate cancer

Indexed keywords

BLADDER CANCER; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; EMBASE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; KIDNEY CANCER; KIDNEY FUNCTION; MEDICAL LITERATURE; MEDLINE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

CARCINOMA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; KIDNEY NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS; VALIDATION STUDIES AS TOPIC;

EID: 83955164234     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.09.019     Document Type: Review

References (99)

1. D. Le Bihan, E. Breton, D. Lallemand, M.L. Aubin, J. Vignaud, and M. Laval-Jeantet Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging Radiology 168 1988 497 505
2. P.W. Schaefer, P.E. Grant, and R.G. Gonzalez Diffusion-weighted MR imaging of the brain Radiology 217 2000 331 345
3. J.G. Merino, and S. Warach Imaging of acute stroke Nat Rev Neurol 6 2010 560 571
4. H.C. Thoeny, and F. De Keyzer Extracranial applications of diffusion-weighted magnetic resonance imaging Eur Radiol 17 2007 1385 1393
5. H.C. Thoeny, and B.D. Ross Predicting and monitoring cancer treatment response with diffusion-weighted MRI J Magn Reson Imaging 32 2010 2 16
6. P.M. Bossuyt, J.B. Reitsma, and D.E. Bruns Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative Radiology 226 2003 24 28
7. H.C. Thoeny, F. De Keyzer, C. Boesch, and R. Hermans Diffusion-weighted imaging of the parotid gland: influence of the choice of b-values on the apparent diffusion coefficient value J Magn Reson Imaging 20 2004 786 790
8. H.C. Thoeny, and F. De Keyzer Diffusion-weighted MR imaging of native and transplanted kidneys Radiology 259 2011 25 38
9. J. Zhang, Y.M. Tehrani, L. Wang, N.M. Ishill, L.H. Schwartz, and H. Hricak Renal masses: characterization with diffusion-weighted MR imaging - a preliminary experience [published correction appears in Radiology 2010;255:1011] Radiology 247 2008 458 464
10. S. Kim, M. Jain, and A.B. Harris T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging Radiology 251 2009 796 807
11. K. Sandrasegaran, C.P. Sundaram, and R. Ramaswamy Usefulness of diffusion-weighted imaging in the evaluation of renal masses AJR Am J Roentgenol 194 2010 438 445
12. B. Taouli, R.K. Thakur, and L. Mannelli Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging Radiology 251 2009 398 407
13. V. Ficarra, M. Brunelli, and L. Cheng Prognostic and therapeutic impact of the histopathologic definition of parenchymal epithelial renal tumors Eur Urol 58 2010 655 668
14. H. Wang, L. Cheng, and X. Zhang Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T Radiology 257 2010 135 143
15. B. Paudyal, P. Paudyal, and Y. Tsushima The role of the ADC value in the characterisation of renal carcinoma by diffusion-weighted MRI Br J Radiol 83 2010 336 343
16. T. Yoshikawa, H. Kawamitsu, and D.G. Mitchell ADC measurement of abdominal organs and lesions using parallel imaging technique AJR Am J Roentgenol 187 2006 1521 1530
17. G. Manenti, M. Di Roma, and S. Mancino Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3 T Radiol Med 113 2008 199 213
18. O. Kilickesmez, E. Inci, and S. Atilla Diffusion-weighted imaging of the renal and adrenal lesions J Comput Assist Tomogr 33 2009 828 833
19. A.B. Rosenkrantz, B.E. Niver, E.F. Fitzgerald, J.S. Babb, H. Chandarana, and J. Melamed Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade AJR Am J Roentgenol 195 2010 W344 W351
20. S. Doanay, E. Kocako, M. Cieki, S. Alami, N. Akpolat, and I. Orhan Ability and utility of diffusion-weighted MRI with different b values in the evaluation of benign and malignant renal lesions Clin Radiol 66 2011 420 425
21. A.A. Razek, A. Farouk, A. Mousa, and N. Nabil Role of diffusion-weighted magnetic resonance imaging in characterization of renal tumors J Comput Assist Tomogr 35 2011 332 336
22. Inci E, Hocaoglu E, Aydin S, Cimilli T. Diffusion-weighted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification. Eur J Radiol. In press.
23. A. Heidenreich, J. Bellmunt, and M. Bolla EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 2011 61 71
24. H. Miao, H. Fukatsu, and T. Ishigaki Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging Eur J Radiol 61 2007 297 302
25. A. Tanimoto, J. Nakashima, H. Kohno, H. Shinmoto, and S. Kuribayashi Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging J Magn Reson Imaging 25 2007 146 152
26. M.A. Haider, T.H. van der Kwast, and J. Tanguay Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer AJR Am J Roentgenol 189 2007 323 328
27. H.K. Lim, J.K. Kim, K.A. Kim, and K.S. Cho Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection - a multireader study Radiology 250 2009 145 151
28. K. Yoshimitsu, K. Kiyoshima, and H. Irie Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology J Magn Reson Imaging 27 2008 132 139
29. H. Kajihara, Y. Hayashida, and R. Murakami Usefulness of diffusion-weighted imaging in the localization of prostate cancer Int J Radiat Oncol Biol Phys 74 2009 399 403
30. Y. Mazaheri, H. Hricak, and S.W. Fine Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume Radiology 252 2009 449 457
31. P. Gibbs, M.D. Pickles, and L.W. Turnbull Diffusion imaging of the prostate at 3.0 Tesla Invest Radiol 41 2006 185 188
32. T. Tamada, T. Sone, and Y. Jo Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade J Magn Reson Imaging 28 2008 720 726
33. M.D. Pickles, P. Gibbs, M. Sreenivas, and L.W. Turnbull Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T J Magn Reson Imaging 23 2006 130 134
34. C.K. Kim, B.K. Park, J.J. Han, T.W. Kang, and H.M. Lee Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results J Comput Assist Tomogr 31 2007 449 454
35. G. Manenti, E. Squillaci, M. Di Roma, M. Carlani, S. Mancino, and G. Simonetti In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging Radiol Med 111 2006 1124 1133
36. C. Sato, S. Naganawa, and T. Nakamura Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate J Magn Reson Imaging 21 2005 258 262
37. S.A. Reinsberg, G.S. Payne, and S.F. Riches Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection AJR Am J Roentgenol 188 2007 91 98
38. V. Kumar, N.R. Jagannathan, and R. Kumar Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut-off value to predict malignancy of the peripheral zone NMR Biomed 20 2007 505 511
39. N.M. deSouza, S.A. Reinsberg, E.D. Scurr, J.M. Brewster, and G.S. Payne Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules Br J Radiol 80 2007 90 95
40. J.H. Kim, J.K. Kim, B.W. Park, N. Kim, and K.S. Cho Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region J Magn Reson Imaging 28 2008 1173 1179
41. K. Kitajima, Y. Kaji, K. Kuroda, and K. Sogimura High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio Magn Reson Med Sci 7 2008 93 99
42. B. Zelhof, M. Pickles, and G. Liney Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer BJU Int 103 2009 883 888
43. P. Gibbs, G.P. Liney, M.D. Pickles, B. Zelhof, G. Rodrigues, and L.W. Turnbull Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla Invest Radiol 44 2009 572 576
44. X.Z. Wang, B. Wang, and Z.Q. Gao Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation J Magn Reson Imaging 29 2009 1360 1366
45. C.A. Woodfield, G.A. Tung, D.J. Grand, J.A. Pezzullo, J.T. Machan, and J.F. Renzulli II Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy AJR Am J Roentgenol 194 2010 W316 W322
46. 2 AJR Am J Roentgenol 194 2010 W33 W37
47. A. Oto, A. Kayhan, and Y. Jiang Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging Radiology 257 2010 715 723
48. D.L. Langer, T.H. van der Kwast, and A.J. Evans Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features Radiology 255 2010 485 494
49. J. Yamamura, G. Salomon, and R. Buchert Magnetic resonance imaging of prostate cancer: diffusion-weighted imaging in comparison with sextant biopsy J Comput Assist Tomogr 35 2011 223 228
50. B.K. Park, H.M. Lee, C.K. Kim, H.Y. Choi, and J.W. Park Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy Invest Radiol 43 2008 789 793
51. D. Beyersdorff, A. Winkel, B. Hamm, S. Lenk, S.A. Loening, and M. Taupitz MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results Radiology 234 2005 576 581
52. N.M. deSouza, S.F. Riches, and N.J. Vanas Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer Clin Radiol 63 2008 774 782
53. T. Hambrock, D.M. Somford, and H.J. Huisman Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer Radiology 259 2011 453 461
54. B. Turkbey, V.P. Shah, and Y. Pang Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology 258 2011 488 495
55. H.A. Vargas, O. Akin, and T. Franiel Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness Radiology 259 2011 775 784
56. S. Verma, A. Rajech, and H. Morales Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy AJR Am J Roentgenol 196 2011 374 381
57. G. Petralia, and H.C. Thoeny DW-MRI of the urogenital tract: applications in oncology Cancer Imaging 10 2010 S112 S123
58. S.E. Eggener, P.T. Scardino, and P.C. Walsh Predicting 15-year prostate cancer specific mortality after radical prostatectomy J Urol 185 2011 869 875
59. C.K. Kim, D. Choi, B.K. Park, G.Y. Kwon, and H.K. Lim Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results J Magn Reson Imaging 28 2008 963 969
60. J. Ren, Y. Huan, and H. Wang Seminal vesicle invasion in prostate cancer: prediction with combined T2 weighted and diffusion-weighted MR imaging Eur Radiol 30 2009 351 356
61. N.J. van As, N.M. de Souza, and S.F. Riches A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance Eur Urol 56 2009 981 988
62. S.L. Giles, V.A. Morgan, S.F. Riches, K. Thomas, C. Parker, and N.M. deSouza Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components AJR Am J Roentgenol 196 2011 586 591
63. V.A. Morgan, S.F. Riches, and K. Thomas Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance Br J Radiol 84 2011 31 37
64. K. Nishida, S. Yuen, and K. Kamoi Incremental value of T2-weighted and diffusion-weighted MRI for prediction of biochemical recurrence after radical prostatectomy in clinically localized prostate cancer Acta Radiol 52 2011 120 126
65. S.J. Park, C.K. Kim, B.K. Park, H.M. Lee, and K.S. Lee Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results Eur Radiol 21 2011 1111 1118
66. P. Martino, V. Scattoni, and A.B. Galosi Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU) World J Urol 29 2011 595 605
67. A.C. Westphalen, F.V. Coakley, M. Roach, C.E. McCulloch, and J. Kurhanewicz Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection Radiology 256 2010 485 492
68. C.K. Kim, B.K. Park, and H.M. Lee Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI J Magn Reson Imaging 29 2009 391 397
69. C.K. Kim, B.K. Park, W. Park, and S.S. Kim Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience Abdom Imaging 35 2010 246 252
70. T. Tamada, T. Sone, and Y. Jo Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors AJR Am J Roentgenol 197 2011 408 414
71. M. Warmuth, T. Johansson, and P. Mad Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer Eur Urol 58 2010 803 815 Corrigendum. Eur Urol 2011;59:476
72. P.J. De Visschere, G.O. De Meerleer, J.J. Futterer, and G.M. Villeirs Role of MRI in follow-up after focal therapy for prostate carcinoma AJR Am J Roentgenol 194 2010 1427 1433
73. C.K. Kim, B.K. Park, H.M. Lee, S.S. Kim, and E. Kim MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer AJR Am J Roentgenol 190 2008 1180 1186
74. S. Eggener, G. Salomon, P.T. Scardino, J. De la Rosette, T.J. Polascik, and S. Brewster Focal therapy for prostate cancer: possibilities and limitations Eur Urol 58 2010 57 64
75. M.E. Abou-El-Ghar, A. El-Assmy, H.F. Refaie, and T. El-Diasty Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria Radiology 251 2009 415 421
76. K. Ceylan, K. Taken, and L. Gecit Comparison of cystoscopy with diffusion-weighted magnetic resonance images used in the diagnosis and follow-up of patients with bladder tumors Asian Pacific J Cancer Prev 11 2010 1001 1004
77. M. Matsuki, Y. Inada, F. Tatsugami, M. Tanikake, I. Narabayashi, and Y. Katsuoka Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results Eur Radiol 17 2007 201 204
78. A. El-Assmy, M.E. Abou-El-Ghar, H.F. Refaie, and T. El-Diasty Diffusion-weighted MR imaging in diagnosis of superficial and invasive urinary bladder carcinoma: a preliminary prospective study Scientific World Journal 8 2008 364 370
79. O. Kilikesmez, T. Cimilli, and E. Inci Diffusion-weighted MRI of urinary bladder and prostate cancers Diagn Interv Radiol 15 2009 104 110
80. S. Avcu, H. Akdeniz, O. Unal, and M. Kurdoglu The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions Br J Radiol 84 2011 875 882
81. A. Stenzl, N.C. Cowan, and M. De Santis Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines Eur Urol 59 2011 1009 1018
82. M. Babjuk, W. Oosterlinck, and R. Sylvester EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Eur Urol 59 2011 997 1008
83. A. El-Assmy, M.E. Abou-El-Ghar, and A. Mosbah Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging Eur Radiol 19 2009 1575 1581
84. M. Takeuchi, S. Sasaki, and M. Ito Urinary bladder cancer: diffusion-weighted MR imaging - accuracy for diagnosing T stage and estimating histologic grade Radiology 251 2009 112 121
85. H. Watanabe, M. Kanematsu, and H. Kondo Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value? AJR Am J Roentgenol 192 2009 1361 1366
86. S. Yoshida, F. Koga, and S. Kawakami Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer Urology 75 2010 387 391
87. A. Briganti, M.L. Blute, and J.H. Eastham Pelvic lymph node dissection in prostate cancer Eur Urol 55 2009 1251 1265
88. A. Karl, P.R. Carroll, and J.E. Gschwend The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer Eur Urol 55 2009 826 835
89. C.J. McMahon, N.M. Rofsky, and I. Pedrosa Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging Radiology 254 2010 31 46
90. A. Fleischmann, G.N. Thalmann, R. Markwalder, and U.E. Studer Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor J Clin Oncol 23 2005 2358 2365
91. M.C. Schumacher, F.C. Burkhard, G.N. Thalmann, A. Fleischmann, and U.E. Studer Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy Eur Urol 54 2008 344 352
92. M. Eiber, A.J. Beer, and K. Holzapfel Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging Invest Radiol 45 2010 15 23
93. A.J. Beer, M. Eiber, and M. Souvatzoglou Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer Mol Imaging Biol 13 2011 352 361
94. 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases Eur Urol 60 2011 125 130
95. H.C. Thoeny, M. Triantafyllou, and F.D. Birkhaeuser Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients Eur Urol 55 2009 761 769
96. L. Dickinson, H.U. Ahmed, and C. Allen Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting Eur Urol 59 2011 477 494
97. A.R. Padhani, G. Liu, and D.M. Koh Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations Neoplasia 11 2009 102 125
98. B. Ljungberg, N.C. Cowan, and D.C. Hanbury EAU guidelines on renal cell carcinoma: the 2010 update Eur Urol 58 2010 398 406
99. A. Sciarra, J. Barentsz, and A. Bjartell Advances in magnetic resonance imaging: how they are changing the management of prostate cancer Eur Urol 59 2011 962 977